Forecast 2023
¥0.00
Forecast 2025
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
Forecast 2025
¥0.00
Forecast 2030
TopGraphs Quality Ranking
Underperform
Stock Value
Company Info
P/E
0.00
Beta
0.54
Price-to-book Ratio
0.98
Market Cap
59.01B
TEV
48.76 B
Dividend
¥39.58
Div Yld
1.90%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
¥2,400.00
Industry
Country
ASKA Pharmaceutical Holdings Price Chart
1M
3M
YTD
1Y
2Y
5Y
10Y
20Y
ASKA Pharmaceutical Holdings Stock Forecast 2023
¥2,500.00
In the last five quarters, ASKA Pharmaceutical Holdings’s Price Target has fallen from ¥2,429.89 to ¥2,400.00 - a -1.23% decrease.
20.02%
Last update: 05/11/2024
Highest Price Target ¥3,100.00
Average Price Target ¥2,500.00
Lowest Price Target ¥2,400.00
ASKA Pharmaceutical Holdings Stock Predictions 2025
ASKA Pharmaceutical Holdings Stock Prediction 2030
P/E
0.00
Beta
0.54
Price-to-book Ratio
0.98
Market Cap
59.01B
TEV
48.76 B
Dividend
¥39.58
Div Yld
1.90%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
¥2,400.00
Industry
Country
ASKA Pharmaceutical Holdings Analyst Ratings Frequently Asked Questions
Who are the analysts watching ASKA Pharmaceutical Holdings Co.,Ltd.?
The following analysts have recently covered ASKA Pharmaceutical Holdings:
Citigroup Inc
Citigroup Inc. Research
Ichiyoshi Research Institute Inc.
Mizuho Securities Co., Ltd.
(This information refers to the last 90 days.)
Who are the sell-side analysts watching ASKA Pharmaceutical Holdings Co.,Ltd.?
The following sell-side analysts have recently covered ASKA Pharmaceutical Holdings:
Lee, Seohyun
Yoshida, Masao
Ishida, Yuriko
(This information refers to the last 90 days.)
